OraSure Technologies generates substantial annual turnover driven by global sales of its rapid diagnostic tests, public health screening solutions, and molecular sample collection kits. Audited financial statements filed with regulatory authorities report healthy multi-million dollar consolidated revenues, reflecting steady commercial demand from hospitals, clinical laboratories, public health agencies, and direct-to-consumer retail distribution channels.